Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Modulation of 5-fluorouracil activation of toll-like/MyD88/NF-κB/MAPK pathway by Saccharomyces boulardii CNCM I-745 probiotic.

Justino PFC, Franco AX, Pontier-Bres R, Monteiro CES, Barbosa ALR, Souza MHLP, Czerucka D, Soares PMG.

Cytokine. 2020 Jan;125:154791. doi: 10.1016/j.cyto.2019.154791. Epub 2019 Aug 8.

PMID:
31401369
2.

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections.

Czerucka D, Rampal P.

World J Gastroenterol. 2019 May 14;25(18):2188-2203. doi: 10.3748/wjg.v25.i18.2188. Review.

3.

Saccharomyces boulardii Strain CNCM I-745 Modifies the Mononuclear Phagocytes Response in the Small Intestine of Mice Following Salmonella Typhimurium Infection.

Ibáñez L, Pontier-Bres R, Larbret F, Rekima A, Verhasselt V, Blin-Wakkach C, Czerucka D.

Front Immunol. 2019 Apr 2;10:643. doi: 10.3389/fimmu.2019.00643. eCollection 2019.

4.

The Saccharomyces boulardii CNCM I-745 strain shows protective effects against the B. anthracis LT toxin.

Pontier-Bres R, Rampal P, Peyron JF, Munro P, Lemichez E, Czerucka D.

Toxins (Basel). 2015 Oct 30;7(11):4455-67. doi: 10.3390/toxins7114455.

5.

Saccharomyces boulardii modifies Salmonella typhimurium traffic and host immune responses along the intestinal tract.

Pontier-Bres R, Munro P, Boyer L, Anty R, Imbert V, Terciolo C, André F, Rampal P, Lemichez E, Peyron JF, Czerucka D.

PLoS One. 2014 Aug 13;9(8):e103069. doi: 10.1371/journal.pone.0103069. eCollection 2014.

6.

The anti-mitotic drug griseofulvin induces apoptosis of human germ cell tumor cells through a connexin 43-dependent molecular mechanism.

Mauro V, Carette D, Pontier-Bres R, Dompierre J, Czerucka D, Segretain D, Gilleron J, Pointis G.

Apoptosis. 2013 Apr;18(4):480-91. doi: 10.1007/s10495-012-0800-8.

PMID:
23329179
7.

Saccharomyces boulardii improves intestinal epithelial cell restitution by inhibiting αvβ5 integrin activation state.

Canonici A, Pellegrino E, Siret C, Terciolo C, Czerucka D, Bastonero S, Marvaldi J, Lombardo D, Rigot V, André F.

PLoS One. 2012;7(9):e45047. doi: 10.1371/journal.pone.0045047. Epub 2012 Sep 20.

8.

Modification of Salmonella Typhimurium motility by the probiotic yeast strain Saccharomyces boulardii.

Pontier-Bres R, Prodon F, Munro P, Rampal P, Lemichez E, Peyron JF, Czerucka D.

PLoS One. 2012;7(3):e33796. doi: 10.1371/journal.pone.0033796. Epub 2012 Mar 19.

9.

Calpain 2-dependent IκBα degradation mediates CPT-11 secondary resistance in colorectal cancer xenografts.

Fenouille N, Grosso S, Yunchao S, Mary D, Pontier-Bres R, Imbert V, Czerucka D, Caroli-Bosc FX, Peyron JF, Lagadec P.

J Pathol. 2012 May;227(1):118-29. doi: 10.1002/path.3034. Epub 2012 Feb 9.

PMID:
22069124
10.

Saccharomyces boulardii improves intestinal cell restitution through activation of the α2β1 integrin collagen receptor.

Canonici A, Siret C, Pellegrino E, Pontier-Bres R, Pouyet L, Montero MP, Colin C, Czerucka D, Rigot V, André F.

PLoS One. 2011 Mar 31;6(3):e18427. doi: 10.1371/journal.pone.0018427.

11.

Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection.

Martins FS, Dalmasso G, Arantes RM, Doye A, Lemichez E, Lagadec P, Imbert V, Peyron JF, Rampal P, Nicoli JR, Czerucka D.

PLoS One. 2010 Jan 27;5(1):e8925. doi: 10.1371/journal.pone.0008925.

12.

Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome.

Piche T, Saint-Paul MC, Dainese R, Marine-Barjoan E, Iannelli A, Montoya ML, Peyron JF, Czerucka D, Cherikh F, Filippi J, Tran A, Hébuterne X.

Gut. 2008 Apr;57(4):468-73. doi: 10.1136/gut.2007.127068. Epub 2008 Jan 14.

PMID:
18194987
13.

Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells.

Lagadec P, Griessinger E, Nawrot MP, Fenouille N, Colosetti P, Imbert V, Mari M, Hofman P, Czerucka D, Rousseau D, Berard E, Dreano M, Peyron JF.

Br J Cancer. 2008 Jan 29;98(2):335-44. doi: 10.1038/sj.bjc.6604082. Epub 2008 Jan 8.

14.

Review article: yeast as probiotics -- Saccharomyces boulardii.

Czerucka D, Piche T, Rampal P.

Aliment Pharmacol Ther. 2007 Sep 15;26(6):767-78.

15.

Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes.

Dalmasso G, Cottrez F, Imbert V, Lagadec P, Peyron JF, Rampal P, Czerucka D, Groux H, Foussat A, Brun V.

Gastroenterology. 2006 Dec;131(6):1812-25. Erratum in: Gastroenterology. 2007 Apr;132(4):1637. Foussat, Arnaud [added]; Brun, Valerie [added].

PMID:
17087945
16.

Saccharomyces boulardii prevents TNF-alpha-induced apoptosis in EHEC-infected T84 cells.

Dalmasso G, Loubat A, Dahan S, Calle G, Rampal P, Czerucka D.

Res Microbiol. 2006 Jun;157(5):456-65. Epub 2006 Jan 13.

PMID:
16487684
17.

Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells.

Dahan S, Dalmasso G, Imbert V, Peyron JF, Rampal P, Czerucka D.

Infect Immun. 2003 Feb;71(2):766-73.

18.

Experimental effects of Saccharomyces boulardii on diarrheal pathogens.

Czerucka D, Rampal P.

Microbes Infect. 2002 Jun;4(7):733-9. Review.

PMID:
12067833
20.

Implication of mitogen-activated protein kinases in T84 cell responses to enteropathogenic Escherichia coli infection.

Czerucka D, Dahan S, Mograbi B, Rossi B, Rampal P.

Infect Immun. 2001 Mar;69(3):1298-305.

22.

Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl- secretion in T84 cells.

Czerucka D, Rampal P.

Dig Dis Sci. 1999 Nov;44(11):2359-68.

PMID:
10573387
23.
24.

[Protective effect of attapulgite against rotavirus infections and toxin LT of Escherichia coli].

Roux I, Czerucka D, Rampal P.

Gastroenterol Clin Biol. 1994;18(11):1044-5. French. No abstract available.

PMID:
7705570
25.

[Response of the IRD intestinal epithelial cell line to Clostridium difficile toxins A and B in rats. Effect of Saccharomyces boulardii].

Czerucka D, Nano JL, Bernasconi P, Rampal P.

Gastroenterol Clin Biol. 1991;15(1):22-7. French.

PMID:
1849105
26.

[Response to cholera toxin of 2 epithelial intestinal cell lines. Effect of Saccharomyces boulardii].

Czerucka D, Nano JL, Bernasconi P, Rampal P.

Gastroenterol Clin Biol. 1989 Apr;13(4):383-7. French.

PMID:
2544474
27.

Effect of selenium on the growth of three human colon cancer cell lines.

Nano JL, Czerucka D, Menguy F, Rampal P.

Biol Trace Elem Res. 1989 Apr-May;20(1-2):31-43.

PMID:
2484400
28.

Transformation of Ob17 cells promotes proliferation and differentiation of Ob17 preadipocytes via distinct extracellular intermediates.

Czerucka D, Grimaldi P, Ailhaud G.

Biochem Biophys Res Commun. 1986 May 29;137(1):378-87.

PMID:
3013189
29.

[Lipoprotein lipase and adipocyte differentiation].

Ailhaud G, Amri E, Czerucka D, Forest C, Gaillard D, Grimaldi P, Négrel R, Vannier C.

Reprod Nutr Dev. 1985;25(1B):153-8. Review. French.

PMID:
3887522
30.

ob17 cells transformed by the middle-T-only gene of polyoma virus differentiate in vitro and in vivo into adipose cells.

Grimaldi P, Czerucka D, Rassoulzadegan M, Cuzin F, Ailhaud G.

Proc Natl Acad Sci U S A. 1984 Sep;81(17):5440-4.

32.

Establishment of a human cell line after transformation by a plasmid containing the early region of the SV40 genome.

Forest C, Czerucka D, Negrel R, Ailhaud G.

Cell Biol Int Rep. 1983 Jan;7(1):73-81.

PMID:
6299591

Supplemental Content

Loading ...
Support Center